Ishita Drugs & Industries quarterly results and financials

Ishita Drugs & Industries (BSE 524400)₹74.90+5.49%(9 Nov 2026 close)Pharmaceuticals

Key facts

In the Mar 2026 quarter (standalone), Ishita Drugs & Industries reported sales of ₹3.07 Cr, down 32.8% from Mar 2025, and net profit of ₹0.19 Cr, down 36.7% year on year. For the year to Mar 2026, sales were ₹14.71 Cr and net profit ₹0.79 Cr.

Sales (Mar 2026): ₹3.07 Cr
Net profit (Mar 2026): ₹0.19 Cr
Sales (FY Mar 2026): ₹14.71 Cr
Net profit (FY Mar 2026): ₹0.79 Cr
EPS (Mar 2026): ₹0.61
Borrowings (Mar 2026): ₹0.07 Cr

Company filings, standalone accounts; latest reported quarter Mar 2026

Ishita Drugs & Industries quarterly results

₹ crore unless stated; each column is a quarter.

Ishita Drugs & Industries Quarterly results
	Jun 2023	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026
Sales	3.10	4.41	3.22	4.51	3.04	3.28	4.14	4.57	5.42	3.08	3.15	3.07
Expenses	2.92	4.19	3.00	4.21	2.87	3.04	3.84	4.28	5.08	2.90	3.01	2.97
Operating Profit	0.19	0.23	0.23	0.31	0.18	0.25	0.31	0.30	0.35	0.19	0.15	0.11
OPM %	5.8%	5.0%	6.8%	6.7%	5.6%	7.3%	7.2%	6.4%	6.3%	5.8%	4.5%	3.3%
Other Income	0.06	0.09	0.00	0.09	0.05	0.04	0.06	0.15	0.08	0.06	0.09	0.21
Interest	0.02	0.00	0.03	0.01	0.00	0.00	0.01	0.03	0.01	0.00	0.01	0.01
Depreciation	0.02	0.02	0.02	0.00	0.02	0.02	0.02	0.02	0.02	0.02	0.02	0.01
Profit before tax	0.20	0.29	0.17	0.38	0.20	0.27	0.33	0.39	0.39	0.23	0.20	0.29
Tax %	26.3%	25.0%	25.0%	24.3%	26.3%	23.1%	25.0%	23.7%	23.7%	36.3%	21.0%	35.7%
Net Profit	0.15	0.22	0.13	0.29	0.16	0.20	0.25	0.30	0.31	0.15	0.17	0.19
EPS (Rs)	0.48	0.71	0.41	0.95	0.51	0.65	0.81	0.98	1.01	0.48	0.55	0.61

Ishita Drugs & Industries profit and loss

₹ crore unless stated; years end in March. TTM is the last four quarters.

Ishita Drugs & Industries Profit and loss
	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026	TTM
Sales	7.12	6.46	6.92	9.11	14.88	13.98	14.14	12.10	15.22	15.03	14.71	14.72
Expenses	6.84	6.10	6.47	8.59	14.12	13.07	13.04	11.35	14.33	14.05	13.92	13.96
Operating Profit	0.29	0.37	0.46	0.53	0.77	0.93	1.09	0.77	0.92	1.00	0.78	0.80
OPM %	3.9%	5.6%	6.5%	5.7%	5.1%	6.6%	7.7%	6.3%	6.0%	6.6%	5.2%	5.4%
Other Income	0.12	0.07	0.11	0.15	0.15	0.30	0.10	0.19	0.27	0.33	0.46	0.44
Interest	0.05	0.03	0.10	0.05	0.02	0.02	0.01	0.04	0.08	0.06	0.05	0.03
Depreciation	0.14	0.13	0.13	0.15	0.17	0.14	0.12	0.12	0.10	0.10	0.09	0.07
Profit before tax	0.21	0.27	0.33	0.47	0.72	1.06	1.05	0.79	1.00	1.16	1.09	1.11
Tax %	30.0%	30.8%	25.0%	26.1%	23.9%	20.9%	23.1%	25.6%	24.3%	25.2%	27.8%	—
Net Profit	0.15	0.19	0.26	0.36	0.56	0.84	0.81	0.59	0.76	0.88	0.79	0.82
EPS (Rs)	0.48	0.61	0.85	1.18	1.85	2.79	2.69	1.95	2.52	2.92	2.62	2.65
Dividend payout %	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	—

Ishita Drugs & Industries balance sheet

₹ crore, at each year end.

Ishita Drugs & Industries Balance sheet
	Mar 2015	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026
Equity Capital	2.98	2.99	2.98	2.99	2.98	2.98	2.98	2.99	2.98	2.98	2.98	2.98
Reserves	2.51	2.63	2.83	3.07	3.42	3.98	4.81	5.61	6.18	6.92	7.81	8.59
Borrowings	0.08	1.12	0.00	0.12	0.19	0.28	0.03	0.00	0.95	0.00	3.89	0.07
Other Liabilities	1.37	1.44	1.37	0.97	1.74	2.30	1.43	2.67	1.28	0.90	1.59	0.95
Total Liabilities	6.94	8.18	7.18	7.15	8.33	9.54	9.25	11.27	11.39	10.80	16.27	12.59
Fixed Assets	1.25	1.10	1.01	1.18	1.29	1.13	0.99	0.87	0.88	0.79	0.87	0.87
CWIP	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	1.74
Investments	1.83	2.16	2.71	3.16	4.05	5.30	3.12	4.07	3.40	3.35	3.88	4.47
Other Assets	3.86	4.92	3.46	2.81	2.99	3.11	5.14	6.33	7.11	6.66	11.52	5.51
Inventories	1.30	0.78	0.57	0.73	0.75	0.57	0.66	0.98	1.59	1.07	4.45	0.93
Trade receivables	1.24	1.89	1.71	0.81	1.19	1.32	1.51	0.53	1.79	0.69	1.91	1.02
Cash & equivalents	1.13	2.18	1.10	1.19	1.00	0.99	2.53	4.67	3.42	4.80	4.82	2.69
Total Assets	6.94	8.18	7.18	7.15	8.33	9.54	9.25	11.27	11.39	10.80	16.27	12.59

Ishita Drugs & Industries cash flow

₹ crore, for each year.

Ishita Drugs & Industries Cash flow
	Mar 2015	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026
Cash from operating activity	0.12	0.27	0.51	0.73	0.80	1.04	−0.68	3.07	−2.89	2.11	−3.63	3.93
Cash from investing activity	−0.33	−0.27	−0.54	−0.68	−1.05	−1.14	2.44	−0.92	0.58	0.14	−0.66	−2.23
Cash from financing activity	−0.06	1.06	−1.04	0.04	0.08	0.08	−0.23	0.00	1.04	−0.86	4.32	−3.80
Net cash flow	−0.30	1.06	−1.09	0.09	−0.20	−0.02	1.55	2.15	−1.26	1.39	0.03	−2.14
Capex	0.04	0.00	0.03	0.30	0.26	0.00	0.00	0.01	0.12	0.02	0.17	0.09
Free cash flow	0.05	0.24	0.47	0.40	0.51	1.03	−0.66	3.05	−3.02	2.08	−3.81	2.06
CFO / OP %	35.1%	93.1%	144.1%	160.1%	152.0%	138.1%	−73.0%	285.0%	−382.0%	233.0%	−368.0%	509.1%

Ishita Drugs & Industries ratios

Working-capital days and returns, by year.

Ishita Drugs & Industries Ratios
	Mar 2015	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026
Debtor days	61	97	96	43	47	32	40	14	54	17	46	25
Inventory days	93	57	52	57	43	19	24	36	69	35	153	34
Days payable	79	92	109	44	80	61	36	74	38	16	33	21
Cash conversion cycle	73	60	38	55	10	−11	27	−25	85	35	165	37
Working capital days	65	11	58	33	9	−10	31	−26	44	23	31	147
ROCE %	5.9%	4.2%	4.7%	7.1%	8.1%	10.6%	14.2%	12.9%	8.8%	10.7%	9.8%	8.6%

Ishita Drugs & Industries: frequently asked questions

What are the latest quarterly results of Ishita Drugs & Industries?

For the Mar 2026 quarter, Ishita Drugs & Industries reported sales of ₹3.07 Cr, down 32.8% year on year and net profit of ₹0.19 Cr, down 36.7% year on year. The operating margin was 3.3%.

What is the annual revenue of Ishita Drugs & Industries?

Ishita Drugs & Industries' sales for the year to Mar 2026 were ₹14.71 Cr; over the last twelve months they were ₹14.72 Cr.

What is the net profit of Ishita Drugs & Industries?

Net profit for the year to Mar 2026 was ₹0.79 Cr, and ₹0.82 Cr over the last twelve months. Earnings per share over the same trailing period were ₹2.65.

How much debt does Ishita Drugs & Industries have?

Ishita Drugs & Industries reported borrowings of ₹0.07 Cr at Mar 2026, against cash and equivalents of ₹2.69 Cr.

What is the free cash flow of Ishita Drugs & Industries?

Cash from operations was ₹3.93 Cr in the year to Mar 2026; after capital spending, free cash flow was ₹2.06 Cr.

Loading…